Cognitive behavioral therapy (CBT), a form of talk therapy, and medication given separately or in combination can ease fatigue significantly…
Articles by Marisa Wexler, MS
Treatment with docosahexaenoyl ethanolamide (DHEA), an omega-3 fatty acid found in fish oil, reduced inflammation and disease severity in a…
Treatment with CNM-Au8, an experimental oral liquid therapy, led to statistically significant improvements in the health of connections between brain regions…
Using stem cells derived from people with multiple sclerosis (MS), researchers developed cerebral organoids, or “mini-brains,” to better study…
Measuring levels of the protein GFAP in blood can help to predict disability progression that occurs without relapses — so-called…
Treatment with berberine, a compound found in many plants, eased disease severity and showed anti-inflammatory effects in a mouse model…
Primary progressive multiple sclerosis (PPMS) is driven by antibodies in the cerebrospinal fluid (CSF), the liquid around the brain…
PB006, a biosimilar to Biogen’s approved treatment Tysabri (natalizumab), showed similar safety and efficacy as the original medication…
Researchers were able to image the cerebellum — a small, compact region of the brain that plays key roles in…
In evaluating potential treatments for multiple sclerosis (MS) over the past two decades, England’s National Institute for Health and…
Researchers have identified specific areas of brain damage associated with depression in multiple sclerosis (MS), but not with other…
FSD Pharma has submitted an application to Health Canada asking to start a Phase 1 clinical trial of…
Pheno Therapeutics has entered into an agreement with UCB to develop new therapies aimed at remyelination to treat…
A new therapy that delivers an anti-inflammatory compound to nervous system immune cells via cellular “shipping containers” called exosomes showed…
A treatment containing neural stem cells derived from a human fetus was shown to be well tolerated in a small…
A protein in the virus that causes COVID-19 is structurally similar to several proteins targeted by the immune system in…
The amounts of more than 60 species of bacteria are altered in the gut in people with multiple sclerosis…
Multiple tiny injections of myelin-related small proteins alongside suppressors of the activity of dendritic cells, done using a device akin…
Women with chronic health conditions like multiple sclerosis (MS) often experience disbelief and disenfranchisement from healthcare providers when they…
Researchers in Iran are conducting a clinical trial to test the effects of taking ginger supplements for people with…
Multiple Sclerosis News Today brought consistent coverage of the latest scientific research, developments in treatment, and clinical trials for…
Severing the lower part of the vagus nerve — one of the main neurological pathways that connects the brain to…
Foralumab, a nasal spray therapy that Tiziana Life Sciences is developing for multiple sclerosis (MS) and other disorders,…
Researchers have created a computer program that can simulate clinical trial responses for relapsing-remitting multiple sclerosis (RRMS), which may…
Genetic variations in certain genes may increase the risk of developing progressive multifocal leukoencephalopathy (PML), a serious brain infection…
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive…
Daily exposure to 30 minutes of bright light for two weeks led to clinically significant reductions in fatigue scores…
A machine learning algorithm that incorporates genetic data alongside clinical and demographic information may be able to more accurately predict…
Researchers have developed a technique that uses CAR T-cells, a form of cell therapy, to specifically eliminate the self-reactive immune…
Differences in the composition of the gut microbiome are associated with an altered risk of low immune cell counts as…